Strategies For The Biotech Surge
As the race for a coronavirus vaccine heats up, biotech stocks are on fire. And traders are sharing their strategies for – and best bets… Read More »Strategies For The Biotech Surge
As the race for a coronavirus vaccine heats up, biotech stocks are on fire. And traders are sharing their strategies for – and best bets… Read More »Strategies For The Biotech Surge
When investing during a pandemic, or even outside of a pandemic, one asset management firm recommends employing a surprisingly simple strategy in order to generate… Read More »Come On, Get Happy (Stocks)!
Many dividends have become casualties of the COVID-19 pandemic, with more than 175 public companies having reduced their payouts by at least 50%. Fortunately for… Read More »5 Over 5%: Dividend Stocks With Attractive – And Sustainable – Yields
Among the strategies companies have been using to improve their liquidity position in these difficult times is suspending – or cutting – dividend payments. But… Read More »4 Stocks Bucking The Coronavirus Dividend Trend
With less than six months to go until the 2020 election, political predictions markets are active – and understanding some of the key concepts in… Read More »What Political Predictions Markets Can Teach Us About Making Money In The Stock Market
Nobody knows with any certainty how long it will take to have a safe and effective vaccine for COVID-19. And nobody knows with any certainty… Read More »A Basket Full Of COVID-19 Vaccine Stocks
With a small current market cap, a huge total addressable market, and a game-changing platform, this healthcare-technology stock – which has already made some investors… Read More »This Healthcare-Technology Stock Checks All The Boxes For Massive Long-Term Returns
While the pandemic may slow down its roll-out, the 5G revolution is coming. And along with this technological transformation comes a host of potentially lucrative… Read More »2 Stocks With Upside From The 5G Upgrade
Pharmaceutical giant AbbVie has weathered the COVID-19 storm relatively well, with its first-quarter revenue and earnings per share both coming in ahead of analyst estimates.… Read More »What About AbbVie?
After a period of extreme volatility, stocks just experienced their best month in three decades. UBS believes that upward trend is likely to continue –… Read More »After Stocks’ Best Month In Decades, Onwards And Upwards?